Quanta CEO Speaks On US Expansion, Talent Acquisition, And Addressable Markets

Since closing its $245m funding raise, Quanta Dialysis Technologies has been scaling up its commercial infrastructure and bolstering its US presence.  

• Source: Shutterstock

Quanta is focused on bringing its SC+ dialysis system into users’ homes and selling more systems in both America and Europe.

In 2021, Quanta raised $245m in a series D financing round that drew a roster of attractive investors, including Glenview Capital, Novo Holdings (who led and co-led the round, respectively), BlackRock, Eldridge, Sands Capital,

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Clinical Trials

More from R&D